Use of IMGT® Databases and Tools for Antibody Engineering and Humanization
IMGT®, the international ImMunoGeneTics information system® (http://www.imgt.org), was created in 1989 by Marie-Paule Lefranc (Université de Montpellier and CNRS) to manage the huge diversity of the antigen receptors, immunoglobulins (IG) or antibodies, and T cell receptors (TR). The founding of IMG...
Gespeichert in:
Veröffentlicht in: | Antibody Engineering 2018, Vol.1827, p.35-69 |
---|---|
Hauptverfasser: | , , , , |
Format: | Artikel |
Sprache: | eng |
Schlagworte: | |
Online-Zugang: | Volltext |
Tags: |
Tag hinzufügen
Keine Tags, Fügen Sie den ersten Tag hinzu!
|
container_end_page | 69 |
---|---|
container_issue | |
container_start_page | 35 |
container_title | Antibody Engineering |
container_volume | 1827 |
creator | Lefranc, Marie-Paule Ehrenmann, François Kossida, Sofia Giudicelli, Véronique Duroux, Patrice |
description | IMGT®, the international ImMunoGeneTics information system® (http://www.imgt.org), was created in 1989 by Marie-Paule Lefranc (Université de Montpellier and CNRS) to manage the huge diversity of the antigen receptors, immunoglobulins (IG) or antibodies, and T cell receptors (TR). The founding of IMGT® marked the advent of immunoinformatics, which emerged at the interface between immunogenetics and bioinformatics. Standardized sequence and structure analysis of antibody using IMGT® databases and tools allow one to bridge, for the first time, the gap between antibody sequences and three-dimensional (3D) structures. This is achieved through the IMGT Scientific chart rules, based on the IMGT-ONTOLOGY concepts of classification (IMGT gene and allele nomenclature), description (IMGT standardized labels), and numerotation (IMGT unique numbering and IMGT Collier de Perles). IMGT® is acknowledged as the global reference for immunogenetics and immunoinformatics, and its standards are particularly useful for antibody engineering and humanization. IMGT® databases for antibody nucleotide sequences and genes include IMGT/LIGM-DB and IMGT/GENE-DB, respectively, and nucleotide sequence analysis is performed by the IMGT/V-QUEST and IMGT/JunctionAnalysis tools and for NGS by IMGT/HighV-QUEST. In this chapter, we focus on IMGT® databases and tools for amino acid sequences, two-dimensional (2D) and three-dimensional (3D) structures: the IMGT/DomainGapAlign and IMGT Collier de Perles tools and the IMGT/2Dstructure-DB and IMGT/3Dstructure-DB database. IMGT/mAb-DB provides the query interface for monoclonal antibodies (mAb), fusion proteins for immune applications (FPIA), and composite proteins for clinical applications (CPCA) and related proteins of interest (RPI) and links to the proposed and recommended lists of the World Health Organization International Nonproprietary Name (WHO INN) programme, to IMGT/2Dstructure-DB for amino acid sequences, and to IMGT/3Dstructure-DB and its associated tools (IMGT/StructuralQuery, IMGT/DomainSuperimpose) for crystallized antibodies. |
doi_str_mv | 10.1007/978-1-4939-8648-4_3 |
format | Article |
fullrecord | <record><control><sourceid>proquest_hal_p</sourceid><recordid>TN_cdi_hal_primary_oai_HAL_hal_04237636v1</recordid><sourceformat>XML</sourceformat><sourcesystem>PC</sourcesystem><sourcerecordid>2101919140</sourcerecordid><originalsourceid>FETCH-LOGICAL-c2893-7c00f8af9f06fd6b61863d5797fdf44082016cf626ce20aeaebe143594e624c43</originalsourceid><addsrcrecordid>eNpVkc9OGzEQh90_qCCaJ0Cq9kgPhhl7Yq-PEVCCCOolnC3vrg0Lm3W6TpDoQ_Uh-mR4CVSq5jDSbz6NNPMxdoRwggD61OiSIycjDS8VlZys_MAmOcUxGyP6yA7QEHAFwnz6b6b15zwDRVxqmu6zSUoPACAQp4TmC9uXgEaRwQN2fZt8EUNxdXO5_PunOHcbV7nkU-H6pljG2KUixKGY9Zu2is1zcdHftb33Q9vfvSLz7cr17W-3aWP_le0F1yU_eeuH7PbHxfJszhc_L6_OZgtei9JIrmuAULpgAqjQqEphqWQz1UaHJhBBKQBVHZRQtRfgvPOVR5JTQ14Jqkkesu-7vfeus-uhXbnh2UbX2vlsYccMSEitpHrCzB7v2PUQf2192thVm2rfda73cZuswPyKXAQZ_faGbquVb_5tfn9WBnAHpPV4vx9sFeNjsgh2dGazAYt2dGBHQTY7ky-E13-3</addsrcrecordid><sourcetype>Open Access Repository</sourcetype><iscdi>true</iscdi><recordtype>article</recordtype><pqid>2101919140</pqid></control><display><type>article</type><title>Use of IMGT® Databases and Tools for Antibody Engineering and Humanization</title><source>Springer Books</source><creator>Lefranc, Marie-Paule ; Ehrenmann, François ; Kossida, Sofia ; Giudicelli, Véronique ; Duroux, Patrice</creator><contributor>Chames, Patrick ; Nevoltris, Damien</contributor><creatorcontrib>Lefranc, Marie-Paule ; Ehrenmann, François ; Kossida, Sofia ; Giudicelli, Véronique ; Duroux, Patrice ; Chames, Patrick ; Nevoltris, Damien</creatorcontrib><description>IMGT®, the international ImMunoGeneTics information system® (http://www.imgt.org), was created in 1989 by Marie-Paule Lefranc (Université de Montpellier and CNRS) to manage the huge diversity of the antigen receptors, immunoglobulins (IG) or antibodies, and T cell receptors (TR). The founding of IMGT® marked the advent of immunoinformatics, which emerged at the interface between immunogenetics and bioinformatics. Standardized sequence and structure analysis of antibody using IMGT® databases and tools allow one to bridge, for the first time, the gap between antibody sequences and three-dimensional (3D) structures. This is achieved through the IMGT Scientific chart rules, based on the IMGT-ONTOLOGY concepts of classification (IMGT gene and allele nomenclature), description (IMGT standardized labels), and numerotation (IMGT unique numbering and IMGT Collier de Perles). IMGT® is acknowledged as the global reference for immunogenetics and immunoinformatics, and its standards are particularly useful for antibody engineering and humanization. IMGT® databases for antibody nucleotide sequences and genes include IMGT/LIGM-DB and IMGT/GENE-DB, respectively, and nucleotide sequence analysis is performed by the IMGT/V-QUEST and IMGT/JunctionAnalysis tools and for NGS by IMGT/HighV-QUEST. In this chapter, we focus on IMGT® databases and tools for amino acid sequences, two-dimensional (2D) and three-dimensional (3D) structures: the IMGT/DomainGapAlign and IMGT Collier de Perles tools and the IMGT/2Dstructure-DB and IMGT/3Dstructure-DB database. IMGT/mAb-DB provides the query interface for monoclonal antibodies (mAb), fusion proteins for immune applications (FPIA), and composite proteins for clinical applications (CPCA) and related proteins of interest (RPI) and links to the proposed and recommended lists of the World Health Organization International Nonproprietary Name (WHO INN) programme, to IMGT/2Dstructure-DB for amino acid sequences, and to IMGT/3Dstructure-DB and its associated tools (IMGT/StructuralQuery, IMGT/DomainSuperimpose) for crystallized antibodies.</description><identifier>ISSN: 1064-3745</identifier><identifier>ISBN: 9781493986477</identifier><identifier>ISBN: 1493986473</identifier><identifier>EISSN: 1940-6029</identifier><identifier>EISBN: 9781493986484</identifier><identifier>EISBN: 1493986481</identifier><identifier>DOI: 10.1007/978-1-4939-8648-4_3</identifier><identifier>PMID: 30196491</identifier><language>eng</language><publisher>New York, NY: Springer New York</publisher><subject>Amino Acid Sequence ; Animals ; Antibodies, Monoclonal, Humanized ; Antibody humanization ; B cell epitope ; Biochemistry, Molecular Biology ; C domain ; Databases, Protein ; Epitopes ; Humans ; IMGT ; IMGT Collier de Perles ; IMGT unique numbering ; IMGT-ONTOLOGY ; Immunogenetics ; Immunoglobulin ; Life Sciences ; Mice ; Paratope ; Protein Domains ; Protein Engineering ; V domain</subject><ispartof>Antibody Engineering, 2018, Vol.1827, p.35-69</ispartof><rights>Springer Science+Business Media, LLC, part of Springer Nature 2018</rights><rights>Distributed under a Creative Commons Attribution 4.0 International License</rights><woscitedreferencessubscribed>false</woscitedreferencessubscribed><citedby>FETCH-LOGICAL-c2893-7c00f8af9f06fd6b61863d5797fdf44082016cf626ce20aeaebe143594e624c43</citedby><orcidid>0000-0003-0116-9353 ; 0000-0001-8935-7900 ; 0000-0003-2727-0070 ; 0000-0003-2482-0022 ; 0000-0002-2258-468X</orcidid></display><links><openurl>$$Topenurl_article</openurl><openurlfulltext>$$Topenurlfull_article</openurlfulltext><thumbnail>$$Tsyndetics_thumb_exl</thumbnail><linktopdf>$$Uhttps://link.springer.com/content/pdf/10.1007/978-1-4939-8648-4_3$$EPDF$$P50$$Gspringer$$H</linktopdf><linktohtml>$$Uhttps://link.springer.com/10.1007/978-1-4939-8648-4_3$$EHTML$$P50$$Gspringer$$H</linktohtml><link.rule.ids>230,779,780,784,793,885,27923,38253,41440,42509</link.rule.ids><backlink>$$Uhttps://www.ncbi.nlm.nih.gov/pubmed/30196491$$D View this record in MEDLINE/PubMed$$Hfree_for_read</backlink><backlink>$$Uhttps://hal.science/hal-04237636$$DView record in HAL$$Hfree_for_read</backlink></links><search><contributor>Chames, Patrick</contributor><contributor>Nevoltris, Damien</contributor><creatorcontrib>Lefranc, Marie-Paule</creatorcontrib><creatorcontrib>Ehrenmann, François</creatorcontrib><creatorcontrib>Kossida, Sofia</creatorcontrib><creatorcontrib>Giudicelli, Véronique</creatorcontrib><creatorcontrib>Duroux, Patrice</creatorcontrib><title>Use of IMGT® Databases and Tools for Antibody Engineering and Humanization</title><title>Antibody Engineering</title><addtitle>Methods Mol Biol</addtitle><description>IMGT®, the international ImMunoGeneTics information system® (http://www.imgt.org), was created in 1989 by Marie-Paule Lefranc (Université de Montpellier and CNRS) to manage the huge diversity of the antigen receptors, immunoglobulins (IG) or antibodies, and T cell receptors (TR). The founding of IMGT® marked the advent of immunoinformatics, which emerged at the interface between immunogenetics and bioinformatics. Standardized sequence and structure analysis of antibody using IMGT® databases and tools allow one to bridge, for the first time, the gap between antibody sequences and three-dimensional (3D) structures. This is achieved through the IMGT Scientific chart rules, based on the IMGT-ONTOLOGY concepts of classification (IMGT gene and allele nomenclature), description (IMGT standardized labels), and numerotation (IMGT unique numbering and IMGT Collier de Perles). IMGT® is acknowledged as the global reference for immunogenetics and immunoinformatics, and its standards are particularly useful for antibody engineering and humanization. IMGT® databases for antibody nucleotide sequences and genes include IMGT/LIGM-DB and IMGT/GENE-DB, respectively, and nucleotide sequence analysis is performed by the IMGT/V-QUEST and IMGT/JunctionAnalysis tools and for NGS by IMGT/HighV-QUEST. In this chapter, we focus on IMGT® databases and tools for amino acid sequences, two-dimensional (2D) and three-dimensional (3D) structures: the IMGT/DomainGapAlign and IMGT Collier de Perles tools and the IMGT/2Dstructure-DB and IMGT/3Dstructure-DB database. IMGT/mAb-DB provides the query interface for monoclonal antibodies (mAb), fusion proteins for immune applications (FPIA), and composite proteins for clinical applications (CPCA) and related proteins of interest (RPI) and links to the proposed and recommended lists of the World Health Organization International Nonproprietary Name (WHO INN) programme, to IMGT/2Dstructure-DB for amino acid sequences, and to IMGT/3Dstructure-DB and its associated tools (IMGT/StructuralQuery, IMGT/DomainSuperimpose) for crystallized antibodies.</description><subject>Amino Acid Sequence</subject><subject>Animals</subject><subject>Antibodies, Monoclonal, Humanized</subject><subject>Antibody humanization</subject><subject>B cell epitope</subject><subject>Biochemistry, Molecular Biology</subject><subject>C domain</subject><subject>Databases, Protein</subject><subject>Epitopes</subject><subject>Humans</subject><subject>IMGT</subject><subject>IMGT Collier de Perles</subject><subject>IMGT unique numbering</subject><subject>IMGT-ONTOLOGY</subject><subject>Immunogenetics</subject><subject>Immunoglobulin</subject><subject>Life Sciences</subject><subject>Mice</subject><subject>Paratope</subject><subject>Protein Domains</subject><subject>Protein Engineering</subject><subject>V domain</subject><issn>1064-3745</issn><issn>1940-6029</issn><isbn>9781493986477</isbn><isbn>1493986473</isbn><isbn>9781493986484</isbn><isbn>1493986481</isbn><fulltext>true</fulltext><rsrctype>article</rsrctype><creationdate>2018</creationdate><recordtype>article</recordtype><recordid>eNpVkc9OGzEQh90_qCCaJ0Cq9kgPhhl7Yq-PEVCCCOolnC3vrg0Lm3W6TpDoQ_Uh-mR4CVSq5jDSbz6NNPMxdoRwggD61OiSIycjDS8VlZys_MAmOcUxGyP6yA7QEHAFwnz6b6b15zwDRVxqmu6zSUoPACAQp4TmC9uXgEaRwQN2fZt8EUNxdXO5_PunOHcbV7nkU-H6pljG2KUixKGY9Zu2is1zcdHftb33Q9vfvSLz7cr17W-3aWP_le0F1yU_eeuH7PbHxfJszhc_L6_OZgtei9JIrmuAULpgAqjQqEphqWQz1UaHJhBBKQBVHZRQtRfgvPOVR5JTQ14Jqkkesu-7vfeus-uhXbnh2UbX2vlsYccMSEitpHrCzB7v2PUQf2192thVm2rfda73cZuswPyKXAQZ_faGbquVb_5tfn9WBnAHpPV4vx9sFeNjsgh2dGazAYt2dGBHQTY7ky-E13-3</recordid><startdate>2018</startdate><enddate>2018</enddate><creator>Lefranc, Marie-Paule</creator><creator>Ehrenmann, François</creator><creator>Kossida, Sofia</creator><creator>Giudicelli, Véronique</creator><creator>Duroux, Patrice</creator><general>Springer New York</general><scope>NPM</scope><scope>7X8</scope><scope>1XC</scope><orcidid>https://orcid.org/0000-0003-0116-9353</orcidid><orcidid>https://orcid.org/0000-0001-8935-7900</orcidid><orcidid>https://orcid.org/0000-0003-2727-0070</orcidid><orcidid>https://orcid.org/0000-0003-2482-0022</orcidid><orcidid>https://orcid.org/0000-0002-2258-468X</orcidid></search><sort><creationdate>2018</creationdate><title>Use of IMGT® Databases and Tools for Antibody Engineering and Humanization</title><author>Lefranc, Marie-Paule ; Ehrenmann, François ; Kossida, Sofia ; Giudicelli, Véronique ; Duroux, Patrice</author></sort><facets><frbrtype>5</frbrtype><frbrgroupid>cdi_FETCH-LOGICAL-c2893-7c00f8af9f06fd6b61863d5797fdf44082016cf626ce20aeaebe143594e624c43</frbrgroupid><rsrctype>articles</rsrctype><prefilter>articles</prefilter><language>eng</language><creationdate>2018</creationdate><topic>Amino Acid Sequence</topic><topic>Animals</topic><topic>Antibodies, Monoclonal, Humanized</topic><topic>Antibody humanization</topic><topic>B cell epitope</topic><topic>Biochemistry, Molecular Biology</topic><topic>C domain</topic><topic>Databases, Protein</topic><topic>Epitopes</topic><topic>Humans</topic><topic>IMGT</topic><topic>IMGT Collier de Perles</topic><topic>IMGT unique numbering</topic><topic>IMGT-ONTOLOGY</topic><topic>Immunogenetics</topic><topic>Immunoglobulin</topic><topic>Life Sciences</topic><topic>Mice</topic><topic>Paratope</topic><topic>Protein Domains</topic><topic>Protein Engineering</topic><topic>V domain</topic><toplevel>online_resources</toplevel><creatorcontrib>Lefranc, Marie-Paule</creatorcontrib><creatorcontrib>Ehrenmann, François</creatorcontrib><creatorcontrib>Kossida, Sofia</creatorcontrib><creatorcontrib>Giudicelli, Véronique</creatorcontrib><creatorcontrib>Duroux, Patrice</creatorcontrib><collection>PubMed</collection><collection>MEDLINE - Academic</collection><collection>Hyper Article en Ligne (HAL)</collection><jtitle>Antibody Engineering</jtitle></facets><delivery><delcategory>Remote Search Resource</delcategory><fulltext>fulltext</fulltext></delivery><addata><au>Lefranc, Marie-Paule</au><au>Ehrenmann, François</au><au>Kossida, Sofia</au><au>Giudicelli, Véronique</au><au>Duroux, Patrice</au><au>Chames, Patrick</au><au>Nevoltris, Damien</au><format>journal</format><genre>article</genre><ristype>JOUR</ristype><atitle>Use of IMGT® Databases and Tools for Antibody Engineering and Humanization</atitle><jtitle>Antibody Engineering</jtitle><addtitle>Methods Mol Biol</addtitle><date>2018</date><risdate>2018</risdate><volume>1827</volume><spage>35</spage><epage>69</epage><pages>35-69</pages><issn>1064-3745</issn><eissn>1940-6029</eissn><isbn>9781493986477</isbn><isbn>1493986473</isbn><eisbn>9781493986484</eisbn><eisbn>1493986481</eisbn><abstract>IMGT®, the international ImMunoGeneTics information system® (http://www.imgt.org), was created in 1989 by Marie-Paule Lefranc (Université de Montpellier and CNRS) to manage the huge diversity of the antigen receptors, immunoglobulins (IG) or antibodies, and T cell receptors (TR). The founding of IMGT® marked the advent of immunoinformatics, which emerged at the interface between immunogenetics and bioinformatics. Standardized sequence and structure analysis of antibody using IMGT® databases and tools allow one to bridge, for the first time, the gap between antibody sequences and three-dimensional (3D) structures. This is achieved through the IMGT Scientific chart rules, based on the IMGT-ONTOLOGY concepts of classification (IMGT gene and allele nomenclature), description (IMGT standardized labels), and numerotation (IMGT unique numbering and IMGT Collier de Perles). IMGT® is acknowledged as the global reference for immunogenetics and immunoinformatics, and its standards are particularly useful for antibody engineering and humanization. IMGT® databases for antibody nucleotide sequences and genes include IMGT/LIGM-DB and IMGT/GENE-DB, respectively, and nucleotide sequence analysis is performed by the IMGT/V-QUEST and IMGT/JunctionAnalysis tools and for NGS by IMGT/HighV-QUEST. In this chapter, we focus on IMGT® databases and tools for amino acid sequences, two-dimensional (2D) and three-dimensional (3D) structures: the IMGT/DomainGapAlign and IMGT Collier de Perles tools and the IMGT/2Dstructure-DB and IMGT/3Dstructure-DB database. IMGT/mAb-DB provides the query interface for monoclonal antibodies (mAb), fusion proteins for immune applications (FPIA), and composite proteins for clinical applications (CPCA) and related proteins of interest (RPI) and links to the proposed and recommended lists of the World Health Organization International Nonproprietary Name (WHO INN) programme, to IMGT/2Dstructure-DB for amino acid sequences, and to IMGT/3Dstructure-DB and its associated tools (IMGT/StructuralQuery, IMGT/DomainSuperimpose) for crystallized antibodies.</abstract><cop>New York, NY</cop><pub>Springer New York</pub><pmid>30196491</pmid><doi>10.1007/978-1-4939-8648-4_3</doi><tpages>35</tpages><orcidid>https://orcid.org/0000-0003-0116-9353</orcidid><orcidid>https://orcid.org/0000-0001-8935-7900</orcidid><orcidid>https://orcid.org/0000-0003-2727-0070</orcidid><orcidid>https://orcid.org/0000-0003-2482-0022</orcidid><orcidid>https://orcid.org/0000-0002-2258-468X</orcidid></addata></record> |
fulltext | fulltext |
identifier | ISSN: 1064-3745 |
ispartof | Antibody Engineering, 2018, Vol.1827, p.35-69 |
issn | 1064-3745 1940-6029 |
language | eng |
recordid | cdi_hal_primary_oai_HAL_hal_04237636v1 |
source | Springer Books |
subjects | Amino Acid Sequence Animals Antibodies, Monoclonal, Humanized Antibody humanization B cell epitope Biochemistry, Molecular Biology C domain Databases, Protein Epitopes Humans IMGT IMGT Collier de Perles IMGT unique numbering IMGT-ONTOLOGY Immunogenetics Immunoglobulin Life Sciences Mice Paratope Protein Domains Protein Engineering V domain |
title | Use of IMGT® Databases and Tools for Antibody Engineering and Humanization |
url | https://sfx.bib-bvb.de/sfx_tum?ctx_ver=Z39.88-2004&ctx_enc=info:ofi/enc:UTF-8&ctx_tim=2025-01-10T00%3A20%3A56IST&url_ver=Z39.88-2004&url_ctx_fmt=infofi/fmt:kev:mtx:ctx&rfr_id=info:sid/primo.exlibrisgroup.com:primo3-Article-proquest_hal_p&rft_val_fmt=info:ofi/fmt:kev:mtx:journal&rft.genre=article&rft.atitle=Use%20of%20IMGT%C2%AE%20Databases%20and%20Tools%20for%20Antibody%20Engineering%20and%20Humanization&rft.jtitle=Antibody%20Engineering&rft.au=Lefranc,%20Marie-Paule&rft.date=2018&rft.volume=1827&rft.spage=35&rft.epage=69&rft.pages=35-69&rft.issn=1064-3745&rft.eissn=1940-6029&rft.isbn=9781493986477&rft.isbn_list=1493986473&rft_id=info:doi/10.1007/978-1-4939-8648-4_3&rft_dat=%3Cproquest_hal_p%3E2101919140%3C/proquest_hal_p%3E%3Curl%3E%3C/url%3E&rft.eisbn=9781493986484&rft.eisbn_list=1493986481&disable_directlink=true&sfx.directlink=off&sfx.report_link=0&rft_id=info:oai/&rft_pqid=2101919140&rft_id=info:pmid/30196491&rfr_iscdi=true |